Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at TD Cowen
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $224.66 -1%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
TD Cowen analyst Joseph Thome, Ph.D raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $275.00 (from $220.00) while maintaining a Buy rating.
You May Also Be Interested In
- Jazz Pharmaceuticals presents Xywav sleep disorder data at SLEEP 2026 conference
- Citi Upgrades Informa Plc (INF:LN) (IFJPY) to
- BHP Billiton Ltd. (BHP:AU) (BHP) PT Raised to AUD67 at CLSA
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
